Kochia Allergy Shots: The Plains Tumbleweed and the Burning Bush Trap
Kochia (Bassia scoparia, formerly Kochia scoparia) allergy shots treat the dominant invasive tumbleweed weed of the western and northern Great Plains — an emerging climate-change winner whose drought tolerance and herbicide resistance are driving its northward expansion.
Kochia Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to kochia — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of kochia allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of kochia immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of kochia extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for kochia allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing kochia extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription kochia immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat kochia allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Kochia?
The biology, taxonomy, and clinical fingerprint of Kochia — the foundation of how SCIT targets it.
Bassia scoparia (kochia / burning bush weed) forms tumbleweeds in late fall and dominates disturbed alkaline soils across the Great Plains, Intermountain West, and parts of the Desert SW.
- Scientific name
- Bassia scoparia (syn. Kochia scoparia)
- Family
- Amaranthaceae (includes former Chenopodiaceae per APG IV)Amaranth family
- Type
- Annual weed pollen / tumbleweed
- Native to
- Eurasia; introduced and now invasive across western North America
- Allergen proteins
- Koc s 1 (Ole e 1-like — research-described, NOT WHO/IUIS-listed)Koc s 2 (profilin — research-described, NOT WHO/IUIS-listed)
- Particle size
- 15-25 μm (fine; penetrates lower respiratory tract)
- Avoidance difficulty
- Nearly impossible
How Kochia Allergy Presents
Symptoms by body system — useful for distinguishing Kochia sensitivity from overlapping allergies and infections.
Respiratory
- Seasonal rhinitis peaking August-September across Great Plains and Intermountain West
- Sneezing triggered by tumbleweed formation and dispersal in late summer
- Allergic asthma exacerbation — kochia pollen is fine enough to penetrate deep respiratory tract
- Post-nasal drip and chronic throat clearing through fall weed season
- Sinusitis and facial pressure overlapping with kochia pollen peak
Ocular
- Intense allergic conjunctivitis on peak kochia-count days
- Watery, itchy, red eyes worsened by wind and tumbleweed activity
- Periorbital swelling on high-count August days
- Contact lens intolerance during peak kochia season
Dermal
- Contact urticaria from handling kochia plants in field or garden settings
- Skin pruritus during outdoor activity in areas with dense kochia stands
- Eczema exacerbation in atopic patients during high-count periods
Systemic
- Fatigue and sleep disruption during the August-September Plains pollen peak
- Profilin (Koc s 2) cross-reactivity may contribute to OAS symptoms in some patients
- Reduced exercise tolerance during peak pollen weeks in the Great Plains
- Highway-blocking kochia drifts create occupational exposure for drivers and road crews
The most common mistake I see with kochia in Plains patients is confusion over the 'burning bush' name. Bassia scoparia — the allergenic weed — and Euonymus alatus — the ornamental garden shrub — are completely different plants in different families. Kochia is the wind-pollinated weed that dominates disturbed roadsides and fields; Euonymus is insect-pollinated and not a meaningful allergen. If your chart says 'burning bush,' I always confirm we're talking about the weed, not the shrub.
When & Where Kochia Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: August-September with peak late August across Great Plains, Intermountain West, and Desert SW· ~8-10 weeks of intense exposure; drought-tolerant and herbicide-resistant, making it increasingly difficult to control
US Exposure Map
10 high-intensity statesWhat Kochia Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Kochia pollen cross-reacts extensively within Amaranthaceae via the research-described profilin Koc s 2 and the putative Ole e 1-like protein Koc s 1, which are structurally similar to profilins and Ole e 1-like proteins in Russian thistle (Sal k 4, Sal k 5), lamb's quarter (Che a 2), and pigweed (Ama r 2) (Weber 2007 JACI; Mas 2014 PLOS ONE).
Both Plains tumbleweeds; Sal k 4 profilin cross-reacts with Koc s 2; often co-sensitized
Is SCIT Right for Your Kochia Allergy?
Answer 5 questions to see whether kochia allergy shots match your Great Plains or Intermountain West allergy profile.
How severe are your late-summer kochia symptoms (August-September)?
The Kochia SCIT Protocol
Kochia SCIT uses non-standardized Bassia scoparia extract, typically compounded with Russian thistle and lamb's quarter in a fall-weed vial for Plains and Intermountain West polysensitized patients.
Incremental dose escalation from dilute starting concentration, with your first dose and every dose increase supervised live over Zoom by the prescribing allergist, a prescribed epinephrine auto-injector confirmed on hand, and a brief self-observation afterward. Ideally, build-up should be completed at least 12 weeks before the August-September kochia pollen peak to establish protective immunological tolerance before the most intense exposure period. Asthmatic patients should have well-controlled asthma confirmed before each injection.
Monthly injections sustain desensitization through multiple kochia seasons. Because Bassia scoparia allergens are extensively cross-reactive with Russian thistle (Sal k allergens) and lamb's quarter (Che a allergens), a compounded fall-weed vial covering all three is standard practice for Great Plains and Intermountain West polysensitized patients.
After 3-5 years of maintenance, your allergist will assess whether continued monthly injections are warranted based on your current symptom burden and ongoing local kochia exposure — particularly relevant as kochia range expands under climate change.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Kochia SCIT
No published RCT has studied kochia SCIT specifically; efficacy is extrapolated from the closest family evidence (Salsola SCIT, Tabar 2014 JACI) and general weed-pollen immunotherapy data.
- Symptom reduction — Salsola SCIT (Amaranthaceae family extrapolation)42%Tabar AI et al. 2014, JACI 134:99-105, N=48 (closest published Amaranthaceae SCIT RCT)
- Weed-pollen SCIT medication score reduction50%Cox L et al. 2011, JACI 127:S1-55 (AAAAI Practice Parameter — general weed SCIT)
No kochia-specific SCIT RCT exists. Koc s 1 and Koc s 2 are research-described but not WHO/IUIS-listed, limiting component-resolved evidence. The Tabar 2014 JACI Salsola RCT provides the strongest within-family evidence for Amaranthaceae immunotherapy. Allergists in Wichita, Kansas City, Denver, and other Plains cities routinely prescribe kochia-containing weed vials with positive anecdotal clinical results — but patients should be counseled on the evidence extrapolation.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Kochia SCIT Side Effects
Kochia SCIT carries the standard inhalant SCIT side-effect profile; local injection-site reactions are common, systemic reactions are uncommon, and anaphylaxis is rare. With Curex's at-home program, a prescribed epinephrine auto-injector is confirmed on hand and your first dose and every dose change are supervised live over Zoom by the prescribing allergist.
Local reactions
4 documentedSystemic reactions
4 documentedTraditionally kochia SCIT was given only in a clinic, but for eligible maintenance patients Curex enables safe at-home self-administration: a personalized serum sterile-compounded to USP <797> and lot-tested, a prescribed epinephrine auto-injector confirmed on hand before the first injection, and the first dose plus every dose change supervised live over Zoom by the prescribing allergist. Systemic reactions almost always begin within the first 30 minutes, so a brief post-injection self-observation is advised.
SCIT vs Alternatives for Kochia
Kochia-sensitized patients in the Great Plains and Intermountain West have four main options — SCIT, SLIT drops, avoidance, and daily medications — with SCIT being the only disease-modifying option.
| Criterion | At-Home SCIT (Curex)Best | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Moderate-High — family extrapolation | Moderate — European data extrapolated | Very limited — ubiquitous Plains weed | Good symptom control |
| 5-yr cost | $3,500-$15,000 | $1,500-$5,000 | Low | $500-$2,000/yr |
| Duration | 3-5 years | 3-5 years | Ongoing | Ongoing daily use |
| Convenience | Weekly at home during build-up, then monthly — no clinic visits | Daily home dosing | Very difficult outdoors | Daily pills/sprays |
| Safety | Prescribed epi on hand; Zoom-supervised first/changed doses (~30-min onset) | Lower systemic risk | Safe | Safe long-term |
| Lasting effect | Yes — post-treatment | Emerging evidence | No | No — returns off meds |
At-Home SCIT (Curex)Best
SLIT
Avoidance
Medications
For Plains and Intermountain patients with multi-year kochia and co-occurring Amaranthaceae sensitization, SCIT provides the most comprehensive fall-weed disease modification. Curex delivers that fall-weed immunotherapy as a weekly shot you give yourself at home for $129/month — a personalized serum sterile-compounded to USP <797> that can combine kochia with Russian thistle and lamb's quarter, your first dose and every dose change supervised live over Zoom by the prescribing allergist, with a prescribed epinephrine auto-injector confirmed on hand — useful for rural patients far from an SCIT clinic.
What Kochia SCIT Actually Costs
Kochia SCIT is typically covered under standard allergy benefit codes by major US insurers when prescribed by a board-certified allergist; prior authorization is routinely required. Patients in AAFA Allergy Capitals like Wichita should confirm weed-pollen immunotherapy benefits specifically, as coverage terms vary by plan. Curex at-home IgE testing identifies specific kochia sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your kochia allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Kochia SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
No — they are completely different plants. The 'burning bush' that is an allergenic weed is Bassia scoparia (formerly Kochia scoparia), a wind-pollinated annual weed that forms tumbleweeds and dominates disturbed soils across the Great Plains, Intermountain West, and Desert SW. The 'burning bush' sold as a landscape ornamental is Euonymus alatus (winged euonymus), an insect-pollinated deciduous shrub in the Celastraceae family — entirely different botanically and not a significant aeroallergen. If your allergy chart lists 'burning bush' or 'kochia,' it refers to Bassia scoparia (ImmunoCAP w17), not the garden ornamental. This is one of the most common naming confusions in Plains allergy practice.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.